Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

Study examine effect of high out-of-pocket drug costs for targeted cancer therapies on patients

Study examine effect of high out-of-pocket drug costs for targeted cancer therapies on patients

Experimental drug inhibits BTK molecule in patients with chronic lymphocytic leukemia

Experimental drug inhibits BTK molecule in patients with chronic lymphocytic leukemia

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

Preclinical data shows BGB324 as potential treatment option for Chronic Myeloid Leukemia

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

BioLineRx reports promising initial results from Phase 2 trial of BL-8040 in AML patients

Studies confirm superiority of Tasigna to Glivec at achieving molecular response in Ph+ CML patients

Studies confirm superiority of Tasigna to Glivec at achieving molecular response in Ph+ CML patients

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Scientists investigate combined action of two different compounds against CML

Scientists investigate combined action of two different compounds against CML

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

Two gene alterations pair up to promote growth of leukemia cells

Two gene alterations pair up to promote growth of leukemia cells

Scientists identify protein that blocks death of high-risk acute lymphoblastic leukemia cells

Scientists identify protein that blocks death of high-risk acute lymphoblastic leukemia cells

UNIGE researchers identify genomic variations associated with trisomy 21

UNIGE researchers identify genomic variations associated with trisomy 21

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Researchers identify ways to inhibit function of key protein linked to stem cell-like behavior in CML

Researchers identify ways to inhibit function of key protein linked to stem cell-like behavior in CML

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

Study results suggest that CNL and aCML patients could be treated with FDA-approved drugs

Increasing unsustainable prices for leukemia drugs represent larger issue across all cancers

Increasing unsustainable prices for leukemia drugs represent larger issue across all cancers

MD Anderson professor to receive award for clinical research excellence at AACR meeting

MD Anderson professor to receive award for clinical research excellence at AACR meeting